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Abstract 
Purpose: The aim of this study was to investigate the influence of torque factor and sprint 
duration on the effects of caffeine on sprint cycling performance. Methods: Using a 
counterbalanced, randomized, double-blind, placebo-controlled design, 13 men completed nine 
trials. In Trial 1, participants completed a series of 6 s sprints at increasing torque factors, to 
determine the torque factor, for each individual, which elicited the highest (TOPTIMAL) peak 
power output (PPO). The remaining trials involved all combinations of torque factor (0.8 
N∙m∙kg-1 versus TOPTIMAL), sprint duration (10 s versus 30 s), and supplementation (caffeine [5 
mg∙kg-1] versus placebo). Results: There was a significant effect of torque factor on PPO, with 
higher values at TOPTIMAL (mean difference: 168 W; 95% likely range: 142 – 195 W). There 
was also a significant effect of sprint duration on PPO, with higher values in 10 s sprints (mean 
difference: 52 W; 95% likely range: 18 – 86 W). However, there was no effect of 
supplementation on PPO (p = 0.056). Nevertheless, there was a significant torque factor × 
sprint duration × supplement interaction (p = 0.036), with post hoc tests revealing that caffeine 
produced a higher PPO (mean difference: 76 W; 95% likely range: 19 – 133 W) when the sprint 
duration was 10 s and the torque factor was TOPTIMAL. Conclusions: The results of this study 
show that when torque factor and sprint duration are optimized, to allow participants to express 
their highest PPO, there is a clear effect of caffeine on sprinting performance.  
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3 
 
Introduction 
Caffeine, is a ubiquitous socially acceptable drug which, since 2004, is no longer on the World 
Anti-Doping Agency Prohibited List.1 Research into the effects of caffeine on athletic 
performance has been focused largely around endurance exercise, with benefits of up to 6% 
across various modes of exercise.1 Although early research supported a glycogen-sparing mode 
of action, the key mechanism by which caffeine is now believed to enhance athletic 
performance is via the antagonism of adenosine receptors.1,2 Given the abundance of adenosine 
receptors and their ability to elicit multiple responses, depending on which of the four receptor 
subtypes is activated, researchers have begun to consider the effects of caffeine on shorter and 
more intense exercise paradigms.  
Most of the research into the effects of caffeine on sprinting performance has been performed 
using 30 s cycle ergometer sprints (3-9) usually with torque factors of 0.75 – 0.90 N·m·kg-1.3-
6,8,9 With the exception of Woolf et al.,9 all have found no effect of caffeine on performance. 
Nevertheless, Anselme et al.10 and Glaister et al.11 observed a significant effect of caffeine on 
peak anaerobic power output as determined from a series of 6 s sprints at incrementally 
increasing torque factors. As such, it seems that the failure of previous research to observe an 
effect of caffeine on sprinting performance could be due to motivational issues associated with 
30 s sprints, insufficient torque factors to allow participants to express their true peak power 
output (PPO), or a combination of the two. Indeed, there is evidence that individuals produce 
a lower PPO during 30 s sprints than 10 s sprints, most likely due to subconscious pacing 
strategies.12 Moreover, the torque factor which produces the highest PPO is generally reported 
to be around 1.0 – 1.25 N·m·kg-1. 10,11,13,14 The aim of the present study therefore, was to 
investigate the influence of torque factor and sprint duration on the ergogenic effects of caffeine 
on sprint cycling performance. 
 
Methods 
Participants 
Thirteen recreationally-active male Sport Science students were recruited for the study which 
was approved by St Mary’s University Ethics Committee. The sample size was based on 
previous research which found a significant effect of caffeine on sprint cycling 
performance.10,11 Means  standard deviation for age, height, body mass, and body fat15 of the 
participants were: 20  2 years, 1.78  0.06 m, 75.3  7.6 kg, and 13.0  4.5%, respectively. 
Prior to testing, participants received written and verbal instructions regarding the nature of the 
investigation and completed a training history questionnaire which indicated that all had been 
actively involved in sport for 11  5 years and that the amount of time spent training each week 
was 8  5 hrs. Prior to commencement, all participants completed a health-screening 
questionnaire and provided written informed consent. Participants were instructed to maintain 
their normal diet throughout the testing period, to avoid food and drink in the hour before each 
trial, and to avoid strenuous exercise 24 hours prior to each trial. Participants were provided 
with a list of dietary sources of caffeine and asked to refrain from consuming these for 24 hours 
prior to each trial. A questionnaire was used to estimate typical daily caffeine consumption. 
All trials were completed at approximately the same time of day with a minimum of 48 hours 
between each.  
 
Design 
4 
 
All participants completed nine trials on an electromagnetically-braked cycle ergometer (Lode 
Excalibur Sport, Groningen, Holland) in a laboratory which was thermostatically controlled at 
19°C. The saddle height and handlebar position for each participant were determined at the 
start of the first trial and remained constant for all subsequent trials. All sprints were performed 
in a seated position using standard pedals fitted with toe clips and straps. In Trial 1 participants 
completed a series of maximal 6 s sprints, interspersed with 5-minute passive recovery periods, 
against increasing torque factors to establish the torque factor which produced the highest 
(TOPTIMAL) peak power output (PPO). The experimental trials (trials 2 – 9) followed a 
counterbalanced, randomized, double-blind design in which torque factor (0.8 N∙m∙kg-1 versus 
TOPTIMAL), sprint duration (10 s versus 30 s), and supplementation (caffeine versus placebo) 
were manipulated such that all possible combinations of conditions were experienced by each 
participant (Figure 1).  
 
Procedures 
To provide sufficient data to examine the peak power/torque relationship, and since previous 
research has suggested that TOPTIMAL occurs at around 1.00 – 1.25 N∙m∙kg-1, 11,13,14 the torque 
factors for Trial 1 were: 0.4, 0.6, 0.8, 0.9, 0.95, 1.0, 1.05, 1.1, 1.15, 1.2, and 1.25 N∙m∙kg-1. If 
peak power had not reached a clear asymptote by 1.25 N∙m∙kg-1, further sprints were completed 
using 0.05 N∙m∙kg-1 increments, until peak power started to decline. Strong verbal 
encouragement was provided during every sprint of every trial and all sprints were performed 
from the same stationary starting position. 5 minutes after completion of the 6 s sprint series, a 
30 s maximal sprint against a torque factor of 0.8 N·m·kg-1 was performed to familiarize 
participants with the demands of a maximal sprint of the type required during the experimental 
trials.16  
In the experimental trials, after blood sampling and supplementation procedures were 
completed (see below), a standardized 3-minute warm-up was conducted during which 
participants cycled at 100 W using a cadence of 80 rpm. The warm up included two 5 s practice 
sprints at increasing intensity (~ 75% and 90% of maximum) to prepare participants for the 
subsequent experimental maximal sprint. 60 s after completion of the warm up, participants 
performed a maximal sprint for the required duration against the appropriate torque factor. 
After each trial, participants performed a cool-down by cycling at 100 W for a minimum of 
three minutes. 
At the start of each trial, and after approximately five minutes of seated rest, resting blood 
samples (~ 5 mL) were drawn from a branch of the basilic vein and collected in lithium-heparin 
tubes (Vacutainer; Becton Dickinson, Oxford, United Kingdom). Apart from Trial 1, 
participants were administered subsequently a gelatine capsule containing 5 mg·kg bm-1 of 
caffeine (MyProtein, Manchester, UK) or placebo (maltodextrin: MyProtein, Manchester, UK). 
After supplementation, participants rested for 45 minutes, to allow blood caffeine 
concentrations to peak,17 before a second blood sample was drawn. Blood samples were 
immediately centrifuged at 3000 rpm for 10 minutes, with subsequently decanted plasma 
samples frozen at -80°C until analysed for caffeine content using high-performance liquid 
chromatography (HPLC). Before analysis, plasma samples were thawed, transferred to a 
separating flask, and made up to 1 mL with HPLC grade water. Following the addition of an 
internal standard, samples underwent solvent extraction using a chloroform/IPA mix 
(85%/15%). Each sample was extracted twice and the organic phase was removed each time. 
The organic phases of each extract were subsequently combined, evaporated to dryness under 
nitrogen, and re-suspended in HPLC grade water. Analysis of caffeine content was carried out 
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by reverse phase HPLC using a C18 column (Zorbax Eclipse Plus, Agilent Technologies Ltd., 
Stockport, UK) with a mobile phase of 80%/20% water/methanol, a flow rate of 1.5 mL∙min-1, 
and UV detection at 274 nm. 
 
Statistical Analyses 
All statistical analyses were conducted using the Statistical Package for the Social Sciences 
(SPSS for Windows, IBM SPSS Inc., Chicago, IL). Measures of centrality and spread are 
presented as means ± standard deviation. A one-way repeated measures ANOVA on PPO in 
the order in which the trials were conducted was used to evaluate the potential influence of 
learning or training effects on the results. Differences between trials in measures of PPO, time 
to PPO (TTPP), and cadence at PPO were evaluated using a three-way (torque factor × sprint 
duration × supplement) ANOVA. α was set at 0.05 for all analyses. Significant interactions 
were followed-up using post hoc tests with Bonferroni adjustments for multiple comparisons. 
The above analyses provided 95% confidence limits for all estimates. 
 
Results  
Mean daily habitual caffeine consumption of the participants was 152 ± 290 mg (median: 60 
mg; range: 0 – 1000 mg). Subject compliance with caffeine restriction prior to each trial was 
confirmed by the fact that in all non-caffeine supplemented conditions, plasma caffeine 
concentrations were low (0.17 ± 0.20 µg·mL-1), whereas values were high (5.31 ± 2.08 µg·mL-
1) following caffeine. There was no significant effect of trial order on measures of PPO (F(7,84) 
= 1.742; p = 0.11). 
TOPTIMAL occurred at a torque factor of 1.19 ± 0.08 N∙m∙kg-1. The effects of torque factor, sprint 
duration, and supplementation on measures of PPO, TTPP, and cadence at PPO are presented 
in Figures 2, 3, and 4, respectively. There was a significant effect of torque factor on PPO 
(F(1,12) = 188.3; p < 0.001), with higher values at TOPTIMAL (mean difference: 168 W; 95% likely 
range: 142 – 195 W). There was also a significant effect of sprint duration on PPO (F(1,12) = 
11.4; p = 0.006), with values being higher in 10 s sprints (mean difference: 52 W; 95% likely 
range: 18 – 86 W). However, there was no effect of supplementation on PPO (F(1,12) = 4.5; p = 
0.056). There were no significant interactions between torque factor × sprint duration (F(1,12) = 
2.5; p = 0.143), torque factor × supplement (F(1,12) = 1.8; p = 0.206), or sprint duration × 
supplement (F(1,12) = 1.1; p = 0.322) on PPO. Nevertheless, there was a significant torque factor 
× sprint duration × supplement interaction (F(1,12) = 5.5; p = 0.036), with post hoc tests revealing 
that caffeine produced a significantly higher PPO (mean difference: 76 W; 95% likely range: 
19 – 133 W) only when the sprint duration was 10 s and the torque factor was TOPTIMAL. 
There was a significant effect of torque factor on TTPP (F(1,12) = 20.5; p = 0.001), with shorter 
times achieved using TOPTIMAL (mean difference: 0.96 s; 95% likely range: 0.50 – 1.42 s). 
However, there were no significant effects of sprint duration (F(1,12) = 2.8; p = 0.118) or 
supplementation (F(1,12) = 4.5; p = 0.055) on TTPP. Moreover, there were no significant 
interactions between torque factor × sprint duration (F(1,12) = 0.2; p = 0.672), torque factor × 
supplement (F(1,12) = 3.4; p = 0.091), sprint duration × supplement (F(1,12) = 0.1; p = 0.816), or 
torque factor × sprint duration × supplement (F(1,12) = 0.2; p = 0.645) on TTPP.   
There were significant effects of torque factor (F(1,12) = 59.3; p < 0.001) and sprint duration 
(F(1,12) = 27.5; p = 0.001) on cadence at PPO. Post hoc tests revealed that cadence was fastest 
with the standard (0.8 N∙m∙kg-1) torque factor (mean difference: 21 rpm; 95% likely range: 15 
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– 27 rpm) and with the 10 s sprint duration (mean difference: 6 rpm; 95% likely range: 4 – 9 
rpm). There was, however, no effect of supplementation on cadence at PPO (F(1,12) = 4.1; p = 
0.065), though there was a significant torque factor × supplement interaction (F(1,12) = 5.8; p = 
0.033); the latter reflecting a pattern suggestive of a dissipation of potential effects of 
supplementation on cadence at PPO as torque factor increased. There were no effects of torque 
factor × sprint duration (F(1,12) = 0.1; p = 0.769), sprint duration × supplement (F(1,12) = 0.2; p = 
0.675), or torque factor × sprint duration × supplement (F(1,12) = 0.5; p = 0.475) on cadence at 
PPO. 
 
Discussion 
The aim of this study was to investigate the effects of caffeine supplementation on sprint 
cycling performance and how those effects are influenced by torque factor and sprint duration. 
The main findings were that sprint performance was influenced by torque factor and sprint 
duration. Moreover, it was only when torque factor and sprint duration were optimized to allow 
participants to express their highest PPO that an effect of caffeine supplementation on sprint 
performance was realised.  
The finding that PPO was influenced by sprint duration confirms previous reports that, despite 
strong verbal encouragement, participants appear to subconsciously adopt pacing strategies in 
30 s sprints;12 as reflected in lower cadences at PPO despite no significant effect of sprint 
duration on TTPP. Moreover, the results of the present study show that irrespective of the 
torque factor utilized, the adoption of a pacing strategy masks any effect of caffeine on PPO 
and, as such, is likely to explain why previous research into the effects of caffeine on 30 s 
sprints has failed to find an effect.3-8 Indeed, the adoption of subconscious pacing strategies in 
30 s sprints may also explain inconsistent findings in other ergogenic aids such as creatine18 
and sodium bicarbonate.19 
In contrast to the above, the effect of torque factor on PPO is more difficult to rationalise, but 
is likely related to neuromuscular constraints associated with high pedalling frequencies.20,21 
In sprint cycling, the cadence which optimizes PPO is reported to vary depending on fitness 
status and muscle fibre type, with optimal values from mathematical models of 120 rpm,22 but 
with values ranging from 100 – 135 rpm in endurance and sprint/power athletes respectively.20 
The torque factor-cadence relationship follows a negative linear response pattern23 with lower 
torque factors leading to higher cadences and vice versa, as reflected in the results of the present 
study. Given that the relationship between cadence and PPO follows an inverted-U response,23 
the faster cadences required to achieve PPO under the standard torque conditions may have 
resulted in suboptimal muscle coordination. Indeed, Samozino et al.21 reported that cadences 
faster than optimal, for each individual, moved force production during each pedal stroke to 
less effective phases of each crank cycle (i.e. later in the downstroke and during the early phase 
of the upstroke). Moreover, the ability to synchronise muscle activity into a coordinated 
efficient movement pattern and to minimise the level of agonist-antagonist coactivation, both 
within and between limbs, is likely to be impaired at cadences faster than optimal.20 In the 
present study, the absence of any effect of supplementation on PPO under the standard torque 
conditions suggests that caffeine does not influence the limitations associated with muscle 
coordination and, as such, provides an explanation as to why most previous studies using torque 
factors lower than optimal have failed to observe an effect of caffeine on sprint cycling 
performance.3-6,8 
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The reason why the present study observed an effect of caffeine on PPO, once methodological 
issues associated with sprint duration and torque were addressed, is most likely due to an 
increase in muscle force production during each crank cycle; particularly given the absence of 
any significant effect of supplementation on cadence at PPO. The importance of strength for 
PPO in sprint cycling is inferred from the fact that PPO is generally greater in men than in 
women and that it increases from childhood to adulthood; peaking at the end of the third 
decade.20 Furthermore, strength training has been shown to improve sprint performance, at 
least in running.24 Although research into the effect of caffeine on muscle strength is limited 
and generally inconclusive,1 there is evidence from a meta-analysis that caffeine appears to 
increase maximal voluntary contraction strength of the knee extensor muscles.25 Moreover, the 
knee extensors provide a large contribution (~ 34%) to overall mechanical energy production 
during cycling26 and knee extensor strength is particularly important during the downstroke of 
each crank revolution.20 Indeed, the fact that the above meta-analysis found no effect of 
caffeine on electrically-evoked measures of strength led the authors to suggest that the effect 
of caffeine on knee extensor strength was most likely attributable to a central nervous system 
(CNS) response;25 particularly since only around 85 – 95% of knee extensor muscles are 
recruited during a maximal voluntary contraction.27 The effects of caffeine on the CNS have 
been attributed to its ability to bind to adenosine receptors and thereby reduce the inhibitory 
effects of adenosine on neurotransmitter release and firing rates.2 Nevertheless, the ubiquitous 
nature of adenosine receptors and the contrasting effects of the various receptor subtypes, 
means that a direct effect of caffeine on muscle function cannot, at present, be completely 
discounted.  
One final point to consider regarding the results of the present study is their application outside 
of the laboratory setting. In contrast to fixed torque factors which may, as in the present study, 
force athletes to chase high cadences to try to maximize performance; in real-world 
environments, cyclists seek to optimize performance via appropriate gear selection. Moreover, 
when bicycles are fitted with fixed gears, as in track cycling, sprinters choose gear ratios which 
allow them to optimize power output.23 As such, the results of the present study suggest that 
caffeine is likely to enhance sprint performance in those athletes. 
 
Conclusion 
The results of the present study confirm the significant effects that sprint duration and torque 
factor have on sprint cycling performance; the former most likely due to subconscious pacing 
issues associated with 30 s sprints, and the latter most likely due to impairments in motor 
control from the fast cadences associated with low torque factors. However, when torque factor 
and sprint duration are optimized to allow participants to express their highest PPO, there is a 
clear effect of caffeine on sprint cycling performance. Moreover, the benefits of caffeine on 
PPO appear to be due to improvements in muscular force during the downstroke of each crank 
cycle, and most likely from a CNS-stimulated increase in the contribution from the knee 
extensor muscles.      
 
Practical Applications 
For those wishing to evaluate sprint cycling performance in the laboratory, it is important to 
recognise that standard Wingate torque factors of around 0.8 N∙m∙kg-1 fail to optimize peak 
power output. As such, it would be prudent to establish the force-velocity profile of an athlete 
before setting the load for a sprint performance test. Even then, peak power output in a 30 s 
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test is likely to be impaired by subconscious pacing strategies. However, when torque factor 
and sprint duration are optimized, as is often the case in real-world settings, caffeine 
supplementation of around 5 mg·kg bm-1, taken approximately 45 minutes prior to exercise, 
has a clear positive effect on sprint cycling performance.   
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Figure 1. A schematic representation of the methods used in the study. TF = Torque factor in 
N·m·kg-1; TOPTIMAL = the torque factor which produced the highest peak power output for each 
participant.   
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Figure 2. The effects of torque factor, sprint duration, and supplementation on peak power 
output during a maximal sprint on an electromagnetically-braked cycle ergometer. Values are 
means, bars are standard deviations. Note: Standard = standard torque factor of 0.8 N∙m∙kg-1; 
Optimal = the torque factor required to optimize peak power output; *significantly different (p 
< 0.05) from placebo at the same torque factor and sprint duration; Δ = the percentage 
difference in peak power output between caffeine and placebo conditions; ES = the effect size 
for paired comparisons. 
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Figure 3. The effects of torque factor, sprint duration, and supplementation on time to peak 
power output during a maximal sprint on an electromagnetically-braked cycle ergometer. 
Values are means, bars are standard deviations. Note: Standard = standard torque factor of 0.8 
N∙m∙kg-1; Optimal = the torque factor required to optimize peak power output. 
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Figure 4. The effects of torque factor, sprint duration, and supplementation on cadence at peak 
power output during a maximal sprint on an electromagnetically-braked cycle ergometer. 
Values are means, bars are standard deviations. Note: Standard = standard torque factor of 0.8 
N∙m∙kg-1; Optimal = the torque factor required to optimize peak power output. 
 
0
20
40
60
80
100
120
140
160
10 s (Standard) 30 s (Standard) 10 s (Optimal) 30 s (Optimal)
C
a
d
e
n
ce
 a
t 
P
e
a
k
 P
o
w
e
r 
(r
p
m
)
Sprint Duration
Placebo
Caffeine
